Literature DB >> 23732467

Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.

Savino Bruno1, Simone Saibeni, Vincenzo Bagnardi, Carmen Vandelli, Massimo De Luca, Martina Felder, Anna Ludovica Fracanzani, Cleofe Prisco, Giovanna Vitaliani, Loredana Simone, Giovanni Battista Gaeta, Maria Stanzione, Marcello Persico, Caterina Furlan, Tommaso Stroffolini, Francesco Salerno, Patrick Maisonneuve, Piero Luigi Almasio.   

Abstract

OBJECTIVES: The occurrence of decompensation marks a crucial turning point in the course of cirrhosis. The purpose of this study was to assess the risk of mortality according to the clinical characteristics of first decompensation, considering also the impact of acute-on-chronic liver failure (AoCLF).
METHODS: We conducted a prospective nationwide inception cohort study in Italy. Decompensation was defined by the presence of ascites, either overt or detected by ultrasonography (UD), gastroesophageal variceal bleeding (GEVB), and hepatic encephalopathy (HE). AoCLF was defined according to the Asian Pacific Association for the Study of the Liver criteria. Multivariable Cox proportional hazards regression was used to analyze the risk of failure (death or orthotopic liver transplantation (OLT)).
RESULTS: A total of 490 consecutive cirrhotic patients (314 males, mean age 60.9±12.6 years) fulfilled the study criteria. AoCLF was identified in 59 patients (12.0%). Among the remaining 431 patients, ascites were found in 330 patients (76.6%): in 257 (77.8%) as overt ascites and in 73 (22.2%) as UD ascites. GEVB was observed in 77 patients (17.9%) and HE in 30 patients (7.0%). After a median follow-up of 33 months, 24 patients underwent OLT and 125 died. The cumulative incidence of failure (death or OLT) after 1, 2, and 3 years was, respectively, 28, 53, and 62% in patients with AoCLF; 10, 18, and 25% in patients with UD ascites; 17, 31, and 41% in patients with overt ascites; and 8, 12, and 24% in patients with GEVB (P<0.0001).
CONCLUSIONS: AoCLF is responsible for a relevant proportion of first decompensation in cirrhotic patients and is associated with the poorest outcome. Patients with UD ascites do not have a negligible mortality rate and require clinical monitoring similar to that of patients with overt ascites.

Entities:  

Mesh:

Year:  2013        PMID: 23732467     DOI: 10.1038/ajg.2013.110

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

Review 1.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

Review 2.  Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem.

Authors:  Guadalupe Garcia-Tsao; Jaime Bosch
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-17       Impact factor: 11.382

3.  The natural history of HCV-related cirrhosis and its temporal progression across the different clinical stages.

Authors:  Eduardo Vilar Gomez; Luis Calzadilla Bertot; Yoan Sanchez Rodriguez; Ana Torres Gonzalez; Yadina Martinez Perez; Ali Yasells Garcia
Journal:  Hepatol Int       Date:  2014-08-23       Impact factor: 6.047

Review 4.  Overview on acute-on-chronic liver failure.

Authors:  Jing Zhang; Shan Gao; Zhongping Duan; Ke-Qin Hu
Journal:  Front Med       Date:  2016-03-14       Impact factor: 4.592

Review 5.  Integrated Model for Patient-Centered Advanced Liver Disease Care.

Authors:  Aanand D Naik; Jennifer Arney; Jack A Clark; Lindsey A Martin; Anne M Walling; Autumn Stevenson; Donna Smith; Steven M Asch; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-26       Impact factor: 13.576

6.  Elevated Fasting Plasma Glucose before Liver Transplantation is Associated with Lower Post-Transplant Survival.

Authors:  Emi Katsura; Tatsuki Ichikawa; Naota Taura; Hisamitsu Miyaaki; Satoshi Miuma; Hidetaka Shibata; Takuya Honda; Masaaki Hidaka; Akihiko Soyama; Fuminao Takeshima; Susumu Eguchi; Kazuhiko Nakao
Journal:  Med Sci Monit       Date:  2016-12-02

7.  Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors.

Authors:  Eileen L Yoon; Tae Yeob Kim; Chang Hyeong Lee; Tae Hun Kim; Hyun Chin Cho; Sang Soo Lee; Sung Eun Kim; Hee Yeon Kim; Chang Wook Kim; Do Seon Song; Jin Mo Yang; Dong Hyun Sinn; Young Kul Jung; Hyung Joon Yim; Hyoung Su Kim; Joo Hyun Sohn; Jeong Han Kim; Won Hyeok Choe; Byung Seok Lee; Moon Young Kim; Soung Won Jeong; Eunhee Choi; Dong Joon Kim
Journal:  J Clin Gastroenterol       Date:  2019-02       Impact factor: 3.062

8.  Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.

Authors:  Apurva S Shah; Deepak N Amarapurkar
Journal:  J Clin Exp Hepatol       Date:  2017-06-15

9.  Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality.

Authors:  Fasiha Kanwal; Thomas J Taylor; Jennifer R Kramer; Yumei Cao; Donna Smith; Allen L Gifford; Hashem B El-Serag; Aanand D Naik; Steven M Asch
Journal:  JAMA Netw Open       Date:  2020-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.